Johan Karlsson Wallman

knuten till universitetet, MD, PhDTidigare namn: JA Karlsson

Projektledare, Läkare, Forskningsprojektdeltagare

Fler filtreringsmöjligheter
  1. 2021
  2. Pain over 2 years after start of biological versus conventional combination treatment in early rheumatoid arthritis: results from the randomised controlled SWEFOT trial

    Tor Olofsson, Johan K Wallman, Anna Jöud, Maria EC Schelin, Sofia Ernestam, Ronald van Vollenhoven, Saedis Saevarsdottir & Jon Lampa, 2021 sep 1, I: Arthritis Care and Research. 73, 9, s. 1312-1321 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

    Ulf Lindström, Bente Glintborg, Daniela Di Giuseppe, Tanja Schjødt Jørgensen, Bjorn Gudbjornsson, Kathrine Lederballe Grøn, Sella Aarrestad Provan, Brigitte Michelsen, Merete Lund Hetland, Johan K. Wallman, Dan Nordström, Nina Trokovic, Thorvardur Jon Love, Niels Steen Krogh, Johan Askling, Lennart T.H. Jacobsson & Lars Erik Kristensen, 2021 aug, I: Rheumatology (Oxford, England). 60, 8, s. 3635-3645

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort

    Elisabeth Mogard, Tor Olofsson, Stefan Bergman, Ann Bremander, Lars-Erik Kristensen, Jack Kvistgaard Olsen, Johan K Wallman & Elisabet Lindqvist, 2021, (E-pub ahead of print) I: The Journal of rheumatology.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis

    Annelies Boonen, Polina Putrik, Mary Lucy Marques, Alessia Alunno, Lydia Abasolo, Dorcas Beaton, Neil Betteridge, Mathilda Bjørk, Maarten Boers, Boryana Boteva, Bruno Fautrel, Francis Guillemin, Elsa F. Mateus, Elena Nikiphorou, Márta Péntek, Fernando Pimentel Santos, Johannes L. Severens, Suzanne M.M. Verstappen, Karen Walker-Bone, Johan Karlsson Wallman & 3 andra, Marieke M. Ter Wee, René Westhovens & Sofia Ramiro, 2021, I: Annals of the Rheumatic Diseases. 80, 9, s. 1116-1123 20219523.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2020
  7. 2019
  8. Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies

    Laura C. Coates, Johan K. Wallman, Dennis McGonagle, Georg A. Schett, Iain B. McInnes, Philip J. Mease, Lawrence Rasouliyan, Erhard Quebe-Fehling, Darren L. Asquith, Andreas E.R. Fasth, Luminita Pricop & Corine Gaillez, 2019 dec 4, I: Arthritis Research & Therapy. 21, 1, 266.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population

    K. Hambardzumyan, C. Hermanrud, P. Marits, N. Vivar, S. Ernestam, J. K. Wallman, R. F. van Vollenhoven, A. Fogdell-Hahn, S. Saevarsdottir & for the SWEFOT study group for the SWEFOT study group, 2019, I: Scandinavian Journal of Rheumatology. 48, 5, s. 362-366

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Serum biomarkers for prediction of response to methotrexate monotherapy in early rheumatoid arthritis: Results from the SWEFOT trial

    Karen Hambardzumyan, Rebecca J. Bolce, Johan K. Wallman, Ronald F. Van Vollenhoven & Saedis Saevarsdottir, 2019, I: Journal of Rheumatology. 46, 6, s. 555-563 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2018
  12. Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis

    Tor Olofsson, Jonas K. Söderling, Anders Gülfe, Lars Erik Kristensen & Johan K. Wallman, 2018, I: Arthritis Care and Research. 70, 11, s. 1712-1716 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2017
  14. A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure

    Karen Hambardzumyan, Saedis Saevarsdottir, Kristina Forslind, Ingemar F. Petersson, JOHAN KARLSSON WALLMAN, Sofia Ernestam, Rebecca J Bolce & Ronald F van Vollenhoven, 2017 maj 1, I: Arthritis & Rheumatology. 69, 5, s. 953-963

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2016
  16. Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden

    JOHAN KARLSSON WALLMAN, Jonas K. Eriksson, Jan Åke Nilsson, Tor Olofsson, Lars Erik Kristensen, Martin Neovius & Pierre Geborek, 2016 jul 1, I: Journal of Rheumatology. 43, 7, s. 1292-1299 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial

    Jonas K Eriksson, JOHAN KARLSSON WALLMAN, Heather Miller, Ingemar F Petersson, Sofia Ernestam, Nancy Vivar, Ronald F van Vollenhoven & Martin Neovius, 2016 mar 25, I: Arthritis Care and Research. 68, 12, s. 1758–1766

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.

    Karen Hambardzumyan, Rebecca J Bolce, Saedis Saevarsdottir, Kristina Forslind, JOHAN KARLSSON WALLMAN, Scott E Cruickshank, Eric H Sasso, David Chernoff & Ronald F van Vollenhoven, 2016, I: RMD Open. 2, 1, s. e000197

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

    Alf Kastbom, Kristina Forslind, Sofia Ernestam, Pierre Geborek, Johan Karlsson, Ingemar Petersson, Saedis Saevarsdottir, Lars Klareskog, Ronald F van Vollenhoven & Karin Lundberg, 2016, I: Annals of the Rheumatic Diseases. 75, 2, s. 356-361

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2015
  21. Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.

    Jonas Eriksson, Johan Karlsson, Johan Bratt, Ingemar Petersson, Ronald van Vollenhoven, Sofia Ernestam, Pierre Geborek & Martin Neovius, 2015, I: Annals of the Rheumatic Diseases. 74, 6, s. 1094-1101

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 2014
  23. Health economics and its measures in rheumatoid arthritis

    Johan Karlsson, 2014, Department of Clinical Sciences, Lund University. 112 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  24. Is Swollen to Tender Joint Count Ratio a New and Useful Clinical Marker for Biologic Drug Response in Rheumatoid Arthritis? Results From a Swedish Cohort

    Lars Erik Kristensen, Henning Bliddal, Robin Christensen, Johan Karlsson, Anders Gülfe, Tore Saxne & Pierre Geborek, 2014, I: Arthritis Care and Research. 66, 2, s. 173-179

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2013
  26. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.

    Johan Karlsson, Martin Neovius, Jan-Åke Nilsson, Ingemar Petersson, Johan Bratt, Ronald F van Vollenhoven, Sofia Ernestam & Pierre Geborek, 2013, I: Annals of the Rheumatic Diseases. 72, 12, s. 1927-1933

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2011
  28. National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.

    Johan Karlsson, Jan-Åke Nilsson, Martin Neovius, Lars Erik Kristensen, Anders Gülfe, Tore Saxne & Pierre Geborek, 2011, I: Annals of the Rheumatic Diseases. 70, s. 2163-2166

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. 2010
  30. 2008